Angiogenesis has an important role in pathophysiology of cancer. FMS-like tyrosine kinase 3 (FLT3) is implicated in hematopoietic malignancies. Their role in childhood acute lymphoblastic leukemia (ALL) pathogenesis needs more enlightenment. Expression of vascular endothelial growth factor receptor-1 and -2 (VEGFR-1 and -2), as well as FLT3 were assessed by flow cytometry in bone marrow (BM) blasts of 55 newly diagnosed children with ALL. Patients included B cell ALL (B-ALL) group (n = 41) and T cell ALL (T-ALL) group (n = 14). Comparison between groups revealed a significant increase in blasts percent (%) expressing FLT3 and FLT3 intensity detected in B-ALL group (p = 0.004 and p = 0.02, respectively). In B-ALL patients, a significant positive correlation was seen between blasts % expressing FLT3 and blasts percentage infiltrating BM (r = 0.405; p = 0.009), also positive correlation was seen between % of blasts expressing VEGFR-1 and VEGFR-2 (r = 0.704; p < 0.001). In T-ALL group, blast % expressing FLT3 revealed significant positive correlations with blast % expressing VEGFR-1, and those expressing VEGFR-2 (r = 0.627; p = 0.016, and r = 0.654; p = 0.01 1 , respectively). In addition, significant correlation was seen in blasts % expressing all; FLT3, VEGFR-1 and -2, with blasts % expressing stem cell marker CD34 (r = 0.826; p = 0.001, r = 0.596; p = 0.041, and r = 0.798; p = 0.002, respectively). Conclusion: Expression of VEGFR-1, VEGFR-2 and FLT3 were demonstrated and linked on leukemic blasts of ALL which highlights their role in pathogenesis. FLT3 expression plays a role in facilitating blasts proliferation in BM in B-ALL. FLT3, VEGFR-1 and -2 could be used in future profiling of CD34 + leukemic stem cell pool in T-ALL.
Faderl, S., O’Brien, S., Pui, C.H., Stock, W., Wetzler, M., Hoelzer, D. and Kantarjian, H.M. (2010) Adult Acute Lymphoblastic Leukemia: Concepts and Strategies. Cancer, 116, 1165-1176. https://doi.org/10.1002/cncr.24862
Ezzat, S., Rashed, W.M., Salem, S., Dorak, M.T., El-Daly, M., Abdel-Hamid, M., Sidhom, I., El-Hadad, A. and Loffredo, C. (2016) Environmental, Maternal, and Reproductive Risk Factors for Childhood Acute Lymphoblastic Leukemia in Egypt: A Case-Control Study. BMC Cancer, 16, 662. https://doi.org/10.1186/s12885-016-2689-z
Adnan Awad, S., Kamel, M.M., Ayoub, M.A., Kamel, A.M., Elnoshokaty, E.H. and El Hifnawi, N. (2016) Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia, 16, S19-S24.e1. https://doi.org/10.1016/j.clml.2016.02.032
Leblebisatan, G., Antmen, B., Sasmaz, I. and Kilinc, Y. (2012) Vascular Endothelial Growth Factor Levels in Childhood Acute Lymphoblastic and Myeloblastic Leukemia. Indian Journal of Hematology and Blood Transfusion, 28, 24-28. https://doi.org/10.1007/s12288-011-0102-2
Diffner, E., Gauffin, F., Anagnostaki, L., Nordgren, A., Gustafsson, B., Sander, B., Gustafsson, B. and Persson, J.L. (2009) Expression of VEGF and VEGF Receptors in Childhood Precursor B-Cell Acute Lymphoblastic Leukemia Evaluated by Immunohistochemistry. Journal of Pediatric Hematology/Oncology, 31, 696-701. https://doi.org/10.1097/MPH.0b013e3181b258df
Persson, A.B. and Buschmann, I.R. (2011) Vascular Growth in Health and Disease. Frontiers in Molecular Neuroscience, 4, 14. https://doi.org/10.3389/fnmol.2011.00014
Murakami, M., Zheng, Y., Hirashima, M., Suda, T., Morita, Y., Ooehara, J., Ema, H., Fong, G.-H. and Shibuya, M. (2008) VEGFR1 Tyrosine Kinase Signaling Promotes Lymphangiogenesis as Well as Angiogenesis Indirectly via Macrophage Recruitment. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 658-664. https://doi.org/10.1161/ATVBAHA.107.150433
Hiratsuka, S., Kataoka, Y., Nakao, K., Nakamura, K., Morikawa, S., Tanaka, S., Katsuki, M., Maru, Y. and Shibuya, M. (2005) Vascular Endothelial Growth Factor A (VEGF-A) Is Involved in Guidance of VEGF Receptor-Positive Cells to the Anterior Portion of Early Embryos. Molecular and Cellular Biology, 25, 355-363. https://doi.org/10.1128/MCB.25.1.355-363.2005
Annesley, C.E. and Brown, P. (2014) The Biology and Targeting of FLT3 in Pediatric Leukemia. Frontiers in Oncology, 4, 263. https://doi.org/10.3389/fonc.2014.00263
Kondo, M., Horibe, K., Takahashi, Y., Matsumoto, K., Fukuda, M., Inaba, J., Kato, K., Kojima, S. and Matsuyama, T. (1999) Prognostic Value of Internal Tandem Duplication of the FLT3 Gene in Childhood Acute Myelogenous Leukemia. Medical and Pediatric Oncology, 33, 525-529. https://doi.org/10.1002/(SICI)1096-911X(199912)33:6 3.3.CO;2-#
Rosnet, O., Bühring, H.J., Marchetto, S., Rappold, I., Lavagna, C., Sainty, D., Arnoulet, C., Chabannon, C., Kanz, L., Hannum, C. and Birnbaum, D. (1996) Human FLT3/FLK2 Receptor Tyrosine Kinase Is Expressed at the Surface of Normal and Malignant Hematopoietic Cells. Leukemia, 10, 238-248.
Karabacak, B.H., Erbey, F., Bayram, I., Yilmaz, S., Acipayam, C., Kilinc, Y. and Tanyeli, A. (2010) Fms-Like Tyrosine Kinase 3 Mutations in Childhood Acute Leukemias and Their Association with Prognosis. Asian Pacific Journal of Cancer Prevention, 11, 923-927.
El-Obeid, A., Sunnuqrut, N., Hussain, A., Al-Hussein, K., Gutiérrez, M.I. and Bhatia, K. (2004) Immature B Cell Malignancies Synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR). Leukemia Research, 28, 133-137. https://doi.org/10.1016/S0145-2126(03)00188-7
Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B. and Albitar, M. (1999) Cellular Vascular Endothelial Growth Factor Is a Predictor of Outcome in Patients with Acute Myeloid Leukemia. Blood, 94, 3717-3721.
Siddaiahgari, S., Awaghad, M. and Latha, M. (2015) Clinical, Immunophenotype and Cytogenetic Profile of Acute Lymphoblastic Leukemia in Children at Tertiary Health Care Centre in India. Muller Journal of Medical Sciences and Research, 6, 112. https://doi.org/10.4103/0975-9727.160676
Stachel, D., Albert, M., Meilbeck, R., Paulides, M. and Schmid, I. (2007) Expression of Angiogenic Factors in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia. Oncology Reports, 17, 147-152. https://doi.org/10.3892/or.17.1.147
Song, G., Li, Y. and Jiang, G. (2012) Role of VEGF/VEGFR in the Pathogenesis of Leukemias and as Treatment Targets (Review). Oncology Reports, 28, 1935-1944. https://doi.org/10.3892/or.2012.2045
Carow, C.E., Levenstein, M., Kaufmann, S.H., Chen, J., Amin, S., Rockwell, P., Witte, L., Borowitz, M.J., Civin, C.I. and Small, D. (1996) Expression of the Hematopoietic Growth Factor Receptor FLT3 (STK-1/Flk2) in Human Leukemias. Blood, 87, 1089-1096.
Pui, C.-H., Robison, L.L. and Look, A.T. (2008) Acute Lymphoblastic Leukaemia. The Lancet, 371, 1030-1043. https://doi.org/10.1016/S0140-6736(08)60457-2
Drexler, H.G. (1996) Expression of FLT3 Receptor and Response to FLT3 Ligand by Leukemic Cells. Leukemia, 10, 588-599.
Vora, H.H., Shukla, S.N., Brahambhatt, B.V., Mehta, S.H., Patel, N.A., Parikh, S.K., Shah, K.N. and Shah, P.M. (2010) Clinical Relevance of FLT3 Receptor Protein Expression in Indian Patients with Acute Leukemia. Asia-Pacific Journal of Clinical Oncology, 6, 306-319. https://doi.org/10.1111/j.1743-7563.2010.01322.x
Peng, H.-L., Zhang, G.-S., Gong, F.-J., Shen, J.-K., Zhang, Y., Xu, Y.-X., Zheng, W.-L., Dai, C.-W., Pei, M.-F. and Yang, J.-J. (2008) Fms-Like Tyrosine Kinase (FLT) 3 and FLT3 Internal Tandem Duplication in Different Types of Adult Leukemia: Analysis of 147 Patients. Croatian Medical Journal, 49, 650-669. https://doi.org/10.3325/cmj.2008.5.650
Terwilliger, T. and Abdul-Hay, M. (2017) Acute Lymphoblastic Leukemia: A Comprehensive Review and 2017 Update. Blood Cancer Journal, 7, e577. https://doi.org/10.1038/bcj.2017.53
Jaime-Pérez, J.C., Pinzón-Uresti, M.A., Jiménez-Castillo, R.A., Colunga-Pedraza, J.E., González-Llano, ó. and Gómez-Almaguer, D. (2018) Relapse of Childhood Acute Lymphoblastic Leukemia and Outcomes at a Reference Center in Latin America: Organomegaly at Diagnosis is a Significant Clinical Predictor. Hematology, 23, 1-9. https://doi.org/10.1080/10245332.2017.1333294
Fukuda, S., Broxmeyer, H.E. and Pelus, L.M. (2005) Flt3 Ligand and the Flt3 Receptor Regulate Hematopoietic Cell Migration by Modulating the SDF-1α (CXCL12)/CXCR4 Axis. Blood, 105, 3117-3126. https://doi.org/10.1182/blood-2004-04-1440
Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M., Lane, W., Wu, Y., Chadburn, A., Hyjek, E., Gill, M., Hicklin, D.J., Witte, L., Moore, M.A.S. and Rafii, S. (2000) Autocrine Stimulation of VEGFR-2 Activates Human Leukemic Cell Growth and Migration. Journal of Clinical Investigation, 106, 511-521. https://doi.org/10.1172/JCI8978
Huang, Y., Chen, X., Dikov, M.M., Novitskiy, S.V., Mosse, C.A., Yang, L. and Carbone, D.P. (2007) Distinct Roles of VEGFR-1 and VEGFR-2 in the Aberrant Hematopoiesis Associated with Elevated Levels of VEGF. Blood, 110, 624-631. https://doi.org/10.1182/blood-2007-01-065714
Fragoso, R., Pereira, T., Wu, Y., Zhu, Z., Cabecadas, J. and Dias, S. (2006) VEGFR-1 (FLT-1) Activation Modulates Acute Lymphoblastic Leukemia Localization and Survival within the Bone Marrow, Determining the Onset of Extramedullary Disease. Blood, 107, 1608-1616. https://doi.org/10.1182/blood-2005-06-2530
Tang, Y.-T., Jiang, F., Guo, L., Si, M.-Y. and Jiao, X.-Y. (2013) The Soluble VEGF Receptor 1 and 2 Expression in Cerebral Spinal Fluid as an Indicator for Leukemia Central Nervous System Metastasis. Journal of Neuro-Oncology, 112, 329-338. https://doi.org/10.1007/s11060-013-1066-x
Dolence, J.J., Gwin, K., Frank, E. and Medina, K.L. (2011) Threshold Levels of Flt3-Ligand Are Required for the Generation and Survival of Lymphoid Progenitors and B-Cell Precursors. European Journal of Immunology, 41, 324-334. https://doi.org/10.1002/eji.201040710
Takahashi, S. (2011) Downstream Molecular Pathways of FLT3 in the Pathogenesis of Acute Myeloid Leukemia: Biology and Therapeutic Implications. Journal of Hematology & Oncology, 4, 13. https://doi.org/10.1186/1756-8722-4-13
Scavelli, C., Vacca, A., Di Pietro, G., Dammacco, F. and Ribatti, D. (2004) Crosstalk between Angiogenesis and Lymphangiogenesis in Tumor Progression. Leukemia, 18, 1054-1058. https://doi.org/10.1038/sj.leu.2403355
Siekmann, I.-K., Dierck, K., Prall, S., Klokow, M., Strauss, J., Buhs, S., Wrzeszcz, A., Bockmayr, M., Beck, F., Trochimiuk, M., Gottschling, K., Martens, V., Khosh-Naucke, M., Gerull, H., Müller, J., Behrmann, L., Blohm, M., Zahedi, R.P., Jeremias, I., Sickmann, A., Nollau, P. and Horstmann, M.A. (2018) Combined Inhibition of Receptor Tyrosine and p21-Activated Kinases as a Therapeutic Strategy in Childhood ALL. Blood Advances, 2, 2554-2567. https://doi.org/10.1182/bloodadvances.2018020693
Noronha, E.P., Andrade, F.G., Zampier, C., de Andrade, C.F.C.G., Terra-Granado, E., Pombo-de-Oliveira, M.S., Melaragno, R., Aranciba, A.M., de Oliveira, C.T., Ikoma, M.R.V., Nóbrega, A.G., Fialho, E.C.C., Neves, G.R., Magalhaes, I.M.Q., Cordoba, J.C., de Brito, P.C., Dias, A.C.S., Costa, J.T., Souza, L.N.S., Santos, M. and Basegio, R.M. (2016) Immunophenotyping with CD135 and CD117 Predicts the FLT3, IL-7R and TLX3 Gene Mutations in Childhood T-Cell Acute Leukemia. Blood Cells, Molecules and Diseases, 57, 74-80. https://doi.org/10.1016/j.bcmd.2015.12.003
Zhang, J., Zhang, Y., Zhang, M., Liu, C., Liu, X., Yin, J., Wu, P., Chen, X., Yang, W., Zhang, L., Guo, Y., Zou, Y., Chen, Y., Cao, Y., Cheng, T. and Zhu, X. (2018) FLT3 Pathway Is a Potential Therapeutic Target for PRC2-Mutated T-Cell Acute Lymphoblastic Leukemia. Blood, 132, 2520-2524. https://doi.org/10.1182/blood-2018-04-845628
Blatt, K., Menzl, I., Eisenwort, G., Cerny-Reiterer, S., Herrmann, H., Herndlhofer, S., Stefanzl, G., Sadovnik, I., Berger, D., Keller, A., Hauswirth, A., Hoermann, G., Willmann, M., Rülicke, T., Sill, H., Sperr, W.R., Mannhalter, C., Melo, J.V., Jager, U., Sexl, V. and Valent, P. (2018) Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+ Stem- and Progenitor Cells in Acute Lymphoblastic Leukemia. Neoplasia, 20, 632-642. https://doi.org/10.1016/j.neo.2018.04.004
Wu, S., Geβner, R., Von Stackelberg, A., Kirchner, R., Henze, G. and Seeger, K. (2005) Cytokine/Cytokine Receptor Gene Expression in Childhood Acute Lymphoblastic Leukemia: Correlation of Expression and Clinical Outcome at First Disease Recurrence. Cancer, 103, 1054-1063. https://doi.org/10.1002/cncr.20869